“Epilepsy (Partial Onset)”的搜索结果，显示 741-750 项，共有 4533 项

1. 神经外科- 医生 - 妙佑医疗国际

   ... epilepsy, Brain tumor-associated epilepsy. 显示更多擅长领域 针对Alfredo Quinones-Hinojosa, M.D.. 申请预约 · 主治专业团队. June 19, 2024. Share on: Facebook ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to compare standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is a Phase III, randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC ...

5. 抑郁症患者的脑部正电子发射断层成像（PET）扫描 - 妙佑医疗国际

   正电子发射断层成像（PET）扫描可以对比患抑郁症时的大脑活动（左侧）和正常的大脑活动（右侧）。蓝色和绿色增加，以及白色和黄色区域减少，显示出抑郁症导致的大脑 ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla. The purpose of this study is to demonstrate pharmacokinetic non-inferiority for nivolumab + relatlimab FDC SC (fixed-dose ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B ...

9. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Rochester, Minn. A Phase 1b/2, open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine: the incidence of hemorrhage in the 3 months following deep vein thrombosis diagnosis in hospitalized malignant ...